Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort
β Scribed by Khanna, Dinesh ;Oh, Myungshin ;Furst, Daniel E. ;Ranganath, Veena ;Gold, Richard H. ;Sharp, John T. ;Park, Grace S. ;Keystone, Edward C. ;Paulus, Harold E. ;,
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 96 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Objective
To evaluate published proposed definitions of minimal disease activity (MDA) and remission in patients with early rheumatoid arthritis (RA).
Methods
The cohort comprised diseaseβmodifying antirheumatic drug (DMARD)βnaive patients with early seropositive active RA (n = 200) treated with traditional DMARDs in the prebiologic era. MDA definitions included Disease Activity Score in 28 joints (DAS28) β€2.85, or achieving 5 of 7 World Health Organization (WHO)/International League of Associations for Rheumatology (ILAR) core set measure thresholds as proposed by the Outcome Measures in Rheumatology Clinical Trials. Other MDA definitions included Simplified Disease Activity Index (SDAI) score β€11 and Clinical Disease Activity Index (CDAI) score β€10. Remission definitions included American College of Rheumatology (ACR) remission, DAS28 <2.6, DAS28 <2.4, achieving all 7 WHO/ILAR core set measure thresholds, SDAI β€3.3, and CDAI β€2.8. Physical function was assessed using the Health Assessment Questionnaire (HAQ) disability index (DI) and radiographic progression was assessed using the Sharp score.
Results
At baseline, no patients were in MDA or remission. Depending on the MDA definition, 20β32%, 27β32%, and 30β48% were in MDA at 6, 12, and 24 months, respectively. Depending on the remission definition, 0.7β15%, 0β24%, and 0β33% were in remission at 6, 12, and 24 months, respectively. For example, at 6 months, lowest (highest) responses for MDA were seen with DAS28 β€2.85 (SDAI β€11) and for remission with ACR remission criteria (DAS28 <2.6). Patients who achieved either MDA or remission had lower HAQ DI and radiographic scores compared with patients who achieved neither.
Conclusion
Our study demonstrated that different proportions of patients were classified as MDA or remission depending on the definition used. This has implications in predefining MDA or remission for a clinical trial or to establish goals for optimum management of RA in clinical practice.
π SIMILAR VOLUMES
## Abstract ## Objective To develop and validate a definition of minimal disease activity (MDA) in patients with juvenile idiopathic arthritis (JIA). ## Methods The clinical charts of JIA patients followed over a 16βyear period were reviewed to identify visits with high disease activity and MDA,
## Abstract ## Objective To establish the frequency and predictors of minimal disease activity in psoriatic arthritis (PsA) and to investigate the prognostic ability of minimal disease activity criteria to predict future joint damage. ## Methods The study was conducted using an observational PsA